Text & Content Analysis

Context: entity (alnylam)  |  Window: 24h Β· 7d Β· 30d  |  Corpus: 1 articles

This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.

Corpus KPIs

Entity
alnylam
Window
Last 7 days
Articles
1
From
2026-07-19 23:41:59+00
To
2026-07-19 23:41:59+00
Range
2026-07-14 12:52:00.550695+00 β†’ 2026-07-21 12:52:00.550695+00
Who’s being talked about

Top Entities

Entity Label Mentions Actions
200 million MONEY 1 πŸ“Š πŸ” 🧲
45 billion MONEY 1 πŸ“Š πŸ” 🧲
accord plasma PERSON 1 πŸ“Š πŸ” 🧲
acg ORG 1 πŸ“Š πŸ” 🧲
ai promises ORG 1 πŸ“Š πŸ” 🧲
alnylam ORG 1 πŸ“Š πŸ” 🧲
apac ORG 1 πŸ“Š πŸ” 🧲
asia LOC 1 πŸ“Š πŸ” 🧲
asian NORP 1 πŸ“Š πŸ” 🧲
astrazeneca ORG 1 πŸ“Š πŸ” 🧲
atlanta astrazeneca invests ORG 1 πŸ“Š πŸ” 🧲
belΓ©n garijo steps PERSON 1 πŸ“Š πŸ” 🧲
bio asia FAC 1 πŸ“Š πŸ” 🧲
bio asiataiwan ORG 1 πŸ“Š πŸ” 🧲
bio asiataiwan 2026 LOC 1 πŸ“Š πŸ” 🧲
build advanced manufacturing facility ORG 1 πŸ“Š πŸ” 🧲
clinical trials go next the frontier that wont ORG 1 πŸ“Š πŸ” 🧲
cmc ORG 1 πŸ“Š πŸ” 🧲
employees facing fertility challenges consider leaving their jobs biomed x ORG 1 πŸ“Š πŸ” 🧲
esco ORG 1 πŸ“Š πŸ” 🧲
expanding us medicine production news ORG 1 πŸ“Š πŸ” 🧲
gmp ORG 1 πŸ“Š πŸ” 🧲
intas group ORG 1 πŸ“Š πŸ” 🧲
iso class ORG 1 πŸ“Š πŸ” 🧲
isoiec ORG 1 πŸ“Š πŸ” 🧲
Who’s talking

Top Sources (Domains)

Domain Articles % Actions
biopharmaapac.com 1 100.00 πŸ“Š πŸ“° 🧲
How the stories are being framed

Top Narrative Frames

Frame Weight Actions
Technology 0.3500 πŸ“Š 🧲
Environment, Climate 0.1700 πŸ“Š 🧲
Government 0.1700 πŸ“Š 🧲
Health 0.1500 πŸ“Š 🧲
Business, Companies 0.1400 πŸ“Š 🧲
Political Theatre 0.0200 πŸ“Š 🧲
How it feels

Sentiment

Label Articles Actions
😐 Neutral 1 πŸ“Š 🧲

Articles included

Top entities
Top sources
Top narrative frames
Pub Date Category Domain Title Analyze Author Sent Score
2026-07-19 23:41:59+00 Science biopharmaapac.com Creative Life Science Showcases Regenerative Medicine Manufacturing Capabilities at BIO Asia–Taiwan 2026 Analyze biopharmaapac.com 😐 neutral 0.1442